
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Drug Discovery Pipeline Knowledge Base</title>
  <link rel="stylesheet" href="styles.css" />
</head>
<body>
  <header>
    <h1>Drug Discovery Pipeline Knowledge Base</h1>
    <p>Comprehensive guide to the stages of drug development</p>
  </header>
  <nav>
    <ul>
      <li><a href="target_identification.html">Target Identification</a></li>
      <li><a href="hit_discovery.html">Hit Discovery</a></li>
      <li><a href="lead_optimization.html">Lead Optimization</a></li>
      <li><a href="preclinical.html">Preclinical Development</a></li>
      <li><a href="clinical.html">Clinical Trials</a></li>
      <li><a href="regulatory.html">Regulatory Approval</a></li>
      <li><a href="post_marketing.html">Post-Marketing Surveillance</a></li>
    </ul>
  </nav>

  <main>
    <section>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Omics Technologies Overview</title>
  <style>
    body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; color: #2c3e50; }
    h1, h2, h3 { color: #34495e; }
    ul { margin-left: 20px; }
    table { border-collapse: collapse; width: 100%; margin-top: 10px; }
    th, td { border: 1px solid #ccc; padding: 8px; text-align: left; }
    th { background-color: #f4f4f4; }
    .section { margin-bottom: 40px; }
  </style>
</head>
<body>

  <h2>Omics Technologies: Systems-Level Insights in Biology</h2>

  <div class="section">
    <h2>1. Genomics – The DNA Blueprint</h2>
    <ul>
      <li><strong>Focus:</strong> Genome structure, variation, and regulation.</li>
      <li><strong>Techniques:</strong> Whole-genome sequencing (WGS), exome sequencing, SNP arrays.</li>
      <li><strong>Applications:</strong> Mutation discovery, patient stratification, gene therapy guidance.</li>
    </ul>
  </div>

  <div class="section">
    <h2>2. Transcriptomics – The RNA Landscape</h2>
    <ul>
      <li><strong>Focus:</strong> Gene expression profiles and RNA dynamics.</li>
      <li><strong>Techniques:</strong> RNA-seq, single-cell RNA-seq, spatial transcriptomics.</li>
      <li><strong>Applications:</strong> Differential expression analysis, cell-type mapping, non-coding RNA discovery.</li>
    </ul>
  </div>

  <div class="section">
    <h2>3. Proteomics – The Functional Machinery</h2>
    <ul>
      <li><strong>Focus:</strong> Protein abundance, modifications, and interactions.</li>
      <li><strong>Techniques:</strong> Mass spectrometry (LC-MS/MS), protein arrays, phosphoproteomics.</li>
      <li><strong>Applications:</strong> Signaling quantification, PTM detection, target validation.</li>
    </ul>
  </div>

  <div class="section">
    <h2>4. Metabolomics – The Chemical Fingerprint</h2>
    <ul>
      <li><strong>Focus:</strong> Small-molecule metabolites and metabolic flux.</li>
      <li><strong>Techniques:</strong> NMR, GC-MS, LC-MS, targeted and untargeted profiling.</li>
      <li><strong>Applications:</strong> Metabolic dysregulation analysis, biomarker discovery, nutritional interventions.</li>
    </ul>
  </div>

  <div class="section">
    <h2>5. Epigenomics – The Regulatory Layer</h2>
    <ul>
      <li><strong>Focus:</strong> DNA and histone modifications influencing gene expression.</li>
      <li><strong>Techniques:</strong> ChIP-seq, ATAC-seq, bisulfite sequencing.</li>
      <li><strong>Applications:</strong> Transcriptional control, epigenetic therapy, chromatin accessibility mapping.</li>
    </ul>
  </div>

  <div class="section">
    <h2>6. Microbiomics – The Host–Microbe Interface</h2>
    <ul>
      <li><strong>Focus:</strong> Composition and function of microbial communities.</li>
      <li><strong>Techniques:</strong> 16S rRNA sequencing, metagenomics, metabolomics integration.</li>
      <li><strong>Applications:</strong> Immune modulation, drug metabolism, infectious disease profiling.</li>
    </ul>
  </div>

  <div class="section">
    <h2>7. Integrative Omics: Systems-Level Insights</h2>
    <table>
      <thead>
        <tr>
          <th>Layer</th>
          <th>Insight</th>
          <th>Example</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>Genomics + Transcriptomics</td>
          <td>Mutation → expression change</td>
          <td>TP53 mutation alters downstream gene regulation</td>
        </tr>
        <tr>
          <td>Transcriptomics + Proteomics</td>
          <td>mRNA–protein correlation</td>
          <td>Cytokine mRNA vs. secreted protein levels</td>
        </tr>
        <tr>
          <td>Proteomics + Metabolomics</td>
          <td>Enzyme activity → metabolite flux</td>
          <td>IDH mutation shifts TCA cycle intermediates</td>
        </tr>
        <tr>
          <td>Multi-omics + AI</td>
          <td>Predict disease states and drug response</td>
          <td>ML models integrating omics for cancer subtyping</td>
        </tr>
      </tbody>
    </table>
  </div>

  <div class="section">
    <h2>8. Strategic Applications in Drug Discovery</h2>
    <ul>
      <li><strong>Target Identification:</strong> Reveal disease-relevant nodes across pathways.</li>
      <li><strong>Target Validation:</strong> Multi-layer evidence strengthens therapeutic rationale.</li>
      <li><strong>Biomarker Discovery:</strong> Guide patient stratification and diagnostics.</li>
      <li><strong>Mechanism of Action:</strong> Track cellular response to drug perturbation.</li>
      <li><strong>Resistance Mechanisms:</strong> Uncover adaptive rewiring via longitudinal profiling.</li>
    </ul>
  </div>



    </section>
  </main>
  <footer>
    <p>&copy; 2025 Drug Discovery Knowledge Base</p>
  </footer>
</body>
</html>
